News | Enterprise Imaging | February 15, 2019

Fujifilm Exhibits Enterprise Imaging Solutions and Artificial Intelligence Initiative at HIMSS 2019

Company highlighted multiple applications for work-in-progress AI platform

Fujifilm Exhibits Enterprise Imaging Solutions and Artificial Intelligence Initiative at HIMSS 2019

February 15, 2019 — Fujifilm Medical Systems U.S.A. Inc. and Fujifilm SonoSite Inc. showcased their enterprise imaging and informatics solutions at the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and exhibition, Feb. 11-15 in Orlando, Fla. Fujifilm's comprehensive Synapse Enterprise Imaging portfolio was available for demonstration in their booth. New this year, SonoSite Synchronicity, Fujifilm's informatics workflow solution designed specifically for point-of-care ultrasound, was also on display. In addition, Fujifilm featured an area within its booth dedicated specifically to its latest advancements in artificial intelligence (AI).

Fujifilm's portfolio of Synapse Enterprise Imaging solutions is comprised of Synapse PACS (picture archiving and communication system), VNA (vendor neutral archive), Cardiology, 3-D, Enterprise Viewer, Cloud Services and Information Systems.

HIMSS attendees were also invited to see first-hand how Fujifilm's AI platform — powered by server-side informatics technology — can help advance patient care, improve workflows and drive new research forward. Under the REiLI brand, the company is working with academic institutions, Synapse customers and company partners to develop AI technologies powered by Fujifilm's deep learning technology and image processing. The AI platform is a work in progress and is not commercially available in the United States.

Applications currently in development include, but are not limited to:

  • Region Recognition, an AI technology to accurately recognize and consistently extract organ regions, regardless of deviations in shape, presence or absence of disease, and imaging conditions;
  • Computer Aided Detection, an AI technology to reduce the time of image interpretation and support radiologists' clinical decision making; and
  • Workflow Support, using AI technology to realize optimal study prioritization, alert communications of AI findings and report population automation.

Visitors to Fujifilm's booth also had the opportunity to see SonoSite Synchronicity software in action. Launched in late 2018 and designed specifically for point-of-care ultrasound, this solution helps healthcare organizations optimize workflows, maximize financial return, improve quality assurance efficiency and streamline credentialing processes.

Adhering to Protected Health Information (PHI) guidelines, the solution helps organizations achieve higher security confidence through Active Directory authentication. Additional features include built-in, customizable worksheets, intuitive dashboards, and the ability to access the tool from a computer, tablet or mobile device. A simplified reporting process ensures all exams are compliant with billing requirements, helping to maximize an organization’s bottom line.

Easily installed and scalable, SonoSite Synchronicity software was engineered to meet every organization's unique requirements for standardization, consistency and compliance across entire medical networks.

For more information: www.fujimed.com

Related Content

John Carrino, M.D., M.Ph., presents “Challenges and Opportunities for Radiology to Prove Value in Alternative Payment Models” at AHRA 2019

John Carrino, M.D., M.Ph., presents “Challenges and Opportunities for Radiology to Prove Value in Alternative Payment Models” at AHRA 2019. Photo by Greg Freiherr

Feature | Radiology Business | July 22, 2019 | By Greg Freiherr
Efforts to reform healthcare are booming, b
IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
Johns Hopkins Named Qualified Provider-led Entity to Develop Criteria for Diagnostic Imaging
News | Clinical Decision Support | July 18, 2019
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School...
Anatomage Releases Anatomage Cloud Platform
News | Remote Viewing Systems | July 16, 2019
Anatomage Inc. released an update to the Anatomage Cloud platform that allows medical and dental professionals to...
Graphic courtesy Pixabay

Graphic courtesy Pixabay

Feature | Artificial Intelligence | July 15, 2019 | By Greg Freiherr
Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient.
Videos | Artificial Intelligence | July 12, 2019
Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by...
Videos | Digital Pathology | July 11, 2019
Toby Cornish, M.D., Ph.D., associate professor and medical director of informatics at the University of Colorado Scho